Cargando…

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer

Our understanding of breast cancer heterogeneity at the protein level is limited despite proteins being the ultimate effectors of cellular functions. We investigated the heterogeneity of breast cancer (41 primary tumors and 15 breast cancer cell lines) at the protein and phosphoprotein levels to ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Ejeh, Fares, Miranda, Mariska, Shi, Wei, Simpson, Peter T., Song, Sarah, Vargas, Ana Cristina, Saunus, Jodi M., Smart, Chanel E., Mariasegaram, Mythily, Wiegmans, Adrian P., Chenevix-Trench, Georgia, Lakhani, Sunil R., Khanna, Kum Kum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102798/ https://www.ncbi.nlm.nih.gov/pubmed/24762669

Ejemplares similares

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib
por: Bessette, Darrell C., et al.
Publicado: (2015)

High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations
por: Johnston, Rebecca L., et al.
Publicado: (2016)

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments
por: Miranda, Mariska, et al.
Publicado: (2015)

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
por: Momeny, Majid, et al.
Publicado: (2015)

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer
por: Saunus, Jodi M., et al.
Publicado: (2022)

Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2019)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers
por: Raghavendra, Ashwini, et al.
Publicado: (2018)

A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy
por: Liu, Chao, et al.
Publicado: (2014)

COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis
por: Hancock, Janelle L., et al.
Publicado: (2023)

RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy
por: Wiegmans, Adrian P., et al.
Publicado: (2016)

BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2007)

Correction: BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2008)

Molecular Aspects of Breast Cancer Metastasis to the Brain
por: Saunus, Jodi M., et al.
Publicado: (2011)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer
por: Spurdle, Amanda B, et al.
Publicado: (2002)

Rare variants in the ATM gene and risk of breast cancer
por: Goldgar, David E, et al.
Publicado: (2011)

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer
por: Da Silva, Leonard, et al.
Publicado: (2010)

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2020)

CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
por: Kalimutho, Murugan, et al.
Publicado: (2018)

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity
por: Smart, Chanel E., et al.
Publicado: (2013)

Correction: In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity
por: Smart, Chanel E., et al.
Publicado: (2013)

miR-139-5p is a regulator of metastatic pathways in breast cancer
por: Krishnan, Keerthana, et al.
Publicado: (2013)

Non-coding RNAs underlie genetic predisposition to breast cancer
por: Moradi Marjaneh, Mahdi, et al.
Publicado: (2020)

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status
por: Flanagan, JM, et al.
Publicado: (2010)

Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer
por: Zeng, Ruichao, et al.
Publicado: (2021)

CX-5461 Enhances the Efficacy of APR-246 via Induction of DNA Damage and Replication Stress in Triple-Negative Breast Cancer
por: Makhale, Ashwini, et al.
Publicado: (2021)

Integrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast Cancer
por: Liu, Chao, et al.
Publicado: (2016)

Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study
por: Kutasovic, Jamie R, et al.
Publicado: (2018)

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
por: Adwal, Alaknanda, et al.
Publicado: (2020)

The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes
por: Johnson, Julie K, et al.
Publicado: (2012)

Mutational Analysis of Triple-Negative Breast Cancer Using Targeted Kinome Sequencing
por: Yoo, Tae-Kyung, et al.
Publicado: (2022)

SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer
por: Burgess, Joshua T., et al.
Publicado: (2016)

No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer
por: Campbell, Ian G, et al.
Publicado: (2004)

SNPs in lncRNA Regions and Breast Cancer Risk
por: Suvanto, Maija, et al.
Publicado: (2020)

Kinome expression profiling and prognosis of basal breast cancers
por: Sabatier, Renaud, et al.
Publicado: (2011)

Characterization of DNA variants in the human kinome in breast cancer
por: Agarwal, Divyansh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2b28vspcbo13nkd0r4grt1c2u7